5 ml of 0.5% bupivacaine infiltrated at each port site is one of 2 therapeutic programs targeting Arthroscopic Surgery. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
2 competitors in Arthroscopic Surgery
5 ml of 0.5% bupivacaine infiltrated at each port site
Bupivacaine %0.25 (isobaric)
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Sources
Details